U.S. drug pricing reform – The Milli Chronicle

Saturday, October 25, 2025

Latest:

Cisco Saudi Arabia Drives Innovation and Strengthens Cybersecurity with AI-Powered Solutions
OIC Conference Highlights Strengthened Collaboration for Water Management Across Member States
Saudi Crown Prince Extends Condolences to Kuwait on Passing of Esteemed Sheikh Ali
Zenos Health Summit Debuts in Diriyah, Showcasing Saudi Arabia’s Leadership in Wellness and Longevity
IBM and AMD bring quantum power to reality

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle October 23, 2025October 23, 2025 drug cost savings analysis, drug price transparency, drug pricing and patient access., fair medicine pricing, health benefit price benchmark, healthcare affordability America, healthcare policy reform, ICER drug cost analysis, ICER economic review, ICER report 2025, ICER value-based pricing model, Medicaid drug costs, Pfizer drug pricing deal, pharmaceutical pricing benchmark, pharmaceutical pricing trends, prescription drug affordability, prescription drug cost reduction, sustainable healthcare system, U.S. drug price alignment, U.S. drug pricing reform, U.S. healthcare efficiency, U.S. healthcare savings, U.S. patient access to medicine, U.S. pharmaceutical innovation, value-based healthcare pricing

Study Highlights $1.5 Billion Savings in U.S. Drug Costs

ICER study shows aligning U.S. drug prices with health value benchmarks could save $1.5 billion and improve patient access. A

Featured News World

NewsDesk Milli Chronicle October 1, 2025October 1, 2025 healthcare policy news, international drug pricing standards, Medicaid drug price cuts, Pfizer CEO Albert Bourla, Pfizer drug prices, Pfizer global pricing, Pfizer lowers drug prices, Pfizer pharmaceutical news, Pfizer shares surge, Pfizer White House agreement, pharmaceutical industry reforms, prescription drug price reform, Trump administration healthcare deal, Trump administration pharma deal, Trump healthcare policy, TrumpRx platform, U.S. drug pricing reform, U.S. healthcare affordability, U.S. prescription drug costs, White House healthcare initiative

Pfizer Strikes Landmark Deal With Trump Administration to Lower Drug Prices

In a move hailed as a turning point for U.S. healthcare, Pfizer agrees to align drug prices with global standards